AVROBIO Inc. (AVRO)
NASDAQ: AVRO
· Real-Time Price · USD
1.40
-0.02 (-1.41%)
At close: Jun 20, 2024, 10:00 PM
AVROBIO Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | -3.6M | n/a | 3.6M | n/a | 3.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 1.8M | n/a | -1.8M | n/a | 1.8M | n/a | 879K | 920K | 3.06M | 336K | 354K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -1.8M | n/a | 1.8M | n/a | 1.8M | n/a | -879K | -920K | -3.06M | -336K | -354K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -18.3M | -17.84M | -19.64M | -12.92M | -7.62M | -9.63M | -22.93M | 68.01M | -25.22M | -25.26M | -22.98M | -27.77M | -29.42M | -27.96M | -32.62M | -31.38M | -26.88M |
Interest Income | 2.44M | 1.59M | 1.95M | 715K | n/a | 1.26M | 1.41M | 444.00 | 248K | 245.00 | 111K | n/a | n/a | n/a | 2K | 9K | 10K |
Pretax Income | -15.91M | -21.19M | -17.72M | -12.27M | -6.81M | -8.41M | -21.58M | 67.48M | -24.96M | -25.03M | -22.97M | -28.05M | -29.83M | -28.23M | -32.61M | -31.39M | -26.9M |
Net Income | -15.91M | -20.81M | -17.72M | -12.64M | -6.81M | -8.79M | -21.58M | 67.48M | -24.12M | 32.57M | -22.84M | -28.33M | -30.25M | -28.23M | -32.61M | -31.39M | -26.9M |
Selling & General & Admin | 5.26M | 2M | 5.32M | 2.07M | 7.26M | 5.24M | 6.26M | 4.58M | 7.89M | 7.12M | 7.07M | 8.9M | 10.16M | 8.96M | 9.58M | 8.83M | 8.36M |
Research & Development | 13.04M | 21.68M | 14.32M | 4.68M | 683K | 4.39M | 14.83M | 11.15M | 17.33M | 18.14M | 15.92M | 18.88M | 19.25M | 19M | 23.04M | 22.54M | 18.53M |
Other Expenses | n/a | 70K | n/a | -70K | n/a | -6K | -51K | -36K | 263K | 223K | -95K | 5K | -45K | -265K | 5K | -21K | -25K |
Operating Expenses | 18.3M | 23.68M | 19.64M | 7.08M | 7.62M | 9.63M | 21.09M | 15.73M | 25.22M | 25.26M | 22.98M | 27.77M | 29.42M | 27.96M | 32.62M | 31.38M | 26.88M |
Interest Expense | -20K | -1.78M | -25K | 1.7M | n/a | 270K | 1.41M | 495K | 248K | 188K | 111K | 285K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 105K | n/a | -105K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 25.48M | n/a | -33.1M | 7.62M | 9.63M | 21.09M | 15.73M | 25.22M | 25.26M | 22.98M | 27.77M | 29.42M | 27.96M | 32.62M | 31.38M | 26.88M |
Income Tax Expense | n/a | 3.03M | n/a | -3.03M | n/a | 377K | n/a | 459K | -839K | -57.6M | -127K | 280K | 415K | n/a | -2K | -9K | -10K |
Shares Outstanding (Basic) | 17.16M | 8.49M | 14.73M | 14.73M | 44.79M | 4.46M | 44.53M | 44.13M | 44.04M | 43.79M | 43.77M | 43.7M | 43.7M | 43.65M | 43.62M | 42.51M | 41.62M |
Shares Outstanding (Diluted) | 17.16M | 8.49M | 14.73M | 14.73M | 44.79M | 4.46M | 44.53M | 44.28M | 44.04M | 43.79M | 43.77M | 43.7M | 43.7M | 43.65M | 43.62M | 42.51M | 41.62M |
EPS (Basic) | -0.93 | -6 | -1.2 | 0.52 | -0.15 | -0.2 | -0.48 | 1.53 | -0.55 | 0.74 | -0.52 | -0.65 | -0.69 | -0.65 | -0.75 | -0.74 | -0.65 |
EPS (Diluted) | -0.93 | -6 | -1.2 | 0.52 | -0.15 | -0.2 | -0.48 | 1.52 | -0.55 | 0.74 | -0.52 | -0.65 | -0.69 | -0.65 | -0.75 | -0.74 | -0.65 |
EBITDA | -18.3M | -23.34M | -19.64M | -7.42M | -7.62M | -9.63M | -19.25M | -15.48M | -25.22M | -25.26M | -22.63M | -27.42M | -29.02M | -27.96M | -32.25M | -31.08M | -26.59M |
EBIT | n/a | 28.31M | n/a | -28.31M | n/a | -8.14M | -20.17M | 67.97M | -24.71M | -24.85M | -22.86M | -27.77M | -30.2M | -28.45M | -32.62M | -31.38M | -26.88M |
Depreciation & Amortization | n/a | -3.77M | n/a | 3.77M | n/a | 43.81K | 3.68M | 289K | 328K | 335K | 352K | 354K | 399K | 436K | 374K | 298K | 291K |